NBIX
Neurocrine Biosciences Inc.
Latest News for NBIX
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Johnson & Johnson (JNJ) and Neurocrine (NBIX). Johnson & Johnson ......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cardiol Therapeutics (CRDL), Neurocrine (NBIX) and I......
In a report released today, from Jefferies maintained a Buy rating on Neurocrine, with a price target of $172.00. In addition to Jefferies, Neurocr......
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neurocrine (NBIX) and Centene (CNC). Neurocrine (NBIX) Wedbush an......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Neurocrine (NBIX), Bausch + Lomb Corporation (BLCO......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Oncolytics Biotech (ONCY) and Neurocrine (NBIX). O......
The latest announcement is out from Neurocrine ( ($NBIX) ). On April 5, 2026, Neurocrine agreed to acquire Soleno Therapeutics via a cash tender of......
Shares in Soleno Therapeutics ($SLNO) zoomed 28% higher in pre-market trading on reports that it could be bought for $2.5 billion by peer Neurocrin......
News data is sourced from MarketXLS API and updated regularly.
Showing 8 of 8 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NBIX | $131.64 | 0% | 820.23K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Neurocrine Biosciences Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW